Case Reports in Orthopedics

Case Reports in Orthopedics / 2019 / Article

Case Report | Open Access

Volume 2019 |Article ID 1328172 | https://doi.org/10.1155/2019/1328172

Lunli Xie, Zhenlin Yan, Jun Zhu, Xudong Chen, Changyuan Yang, Xing Su, Keqin Quan, Dan Pu, "Potential Complications of Percutaneous Vertebroplasty Combined with Interstitial Implantation of 125I Seeds for Metastatic Spinal Tumors: A Case Report and Literary Review", Case Reports in Orthopedics, vol. 2019, Article ID 1328172, 7 pages, 2019. https://doi.org/10.1155/2019/1328172

Potential Complications of Percutaneous Vertebroplasty Combined with Interstitial Implantation of 125I Seeds for Metastatic Spinal Tumors: A Case Report and Literary Review

Academic Editor: Giulio Maccauro
Received29 Mar 2019
Revised16 May 2019
Accepted03 Jun 2019
Published28 Aug 2019

Abstract

Percutaneous vertebroplasty is often used to acquire the stability of the spine and relieve the pain caused by osteoporotic vertebral compressive fracture (OVCF). 125I seeds have been used for application of local therapy for tumors. A combined treatment was reported in previous literatures. Thus, this case report is aimed at reporting a patient with an occurrence of delayed radioactive myelopathy, who accepted percutaneous vertebroplasty combined with interstitial implantation of 125I seeds for metastatic spinal tumors, and at reviewing the published literatures.

1. Introduction

The majority of metastatic spinal tumors occur in the thoracic spine, followed by the lumbar spine and the cervical spine [1]. The vertebral body is easily damaged by spinal metastatic tumors due to its large volume and the abundance of blood vessels within it. Besides, spinal metastasis tumor usually spreads in the vertebral body with aggressive behavior, leading to adverse events such as severe pain, spinal deformity, spinal instability, and even neurologic dysfunction [2]. Thus, various therapeutic methods such as conservative treatments and surgery have been used to treat metastatic spinal lesions [3]. However, the conservative methods including radiotherapy and chemotherapy are limited due to contraindication such as vertebral fractures and spinal instability. Indeed, the patients with metastatic tumors accepted traditional open surgery which always requires long-term postoperative recovery period, often increases mortality, and usually causes delayed treatment for primary tumors [4]. Therefore, the minimally invasive surgical method with percutaneous vertebroplasty (PVP) has been accepted by the surgeon and patient because of nonvascular intervention in injury and reliving of back pain from vertebral body fractures.

Recently, a novel composite therapeutic method defined as the PVP plus interstitial implantation of 125I seeds has been used to copy vertebral body fractures caused by metastatic tumors, and many published literatures have also proved the effectiveness and safety of this combined way [5]. Nevertheless, the potential radioactive myelopathy, in fact, proved by basic research, caused by 125I seeds should be paid more attention by the surgeon in spite of the lack of powerful evidence originating from clinical study. Herein, in the present article, we report a case with radioactive myelopathy and review the published literatures.

2. Case Report

The informed consent was provided by the patient, and ethical approval was warranted by the First People’s Hospital of Huaihua.

A 49-year-old man presented with a 5-month history of back pain who was diagnosed with fourth thoracic vertebral body fracture caused by tumor cells based on pathology results. The tumor cells in the fourth thoracic vertebral body originated from hepatocellular carcinoma. The preoperative thoracic magnetic resonance imaging (MRI) showed a minor intraspinal space-occupying lesion in the fourth thoracic vertebra canal and found pathological fractures of the fourth vertebrae (Figure 1). Back pain as the only clinical symptom without any weakness, numbness, or other symptoms of spinal cord injury in both lower extremities was reported to the physician. And then, he accepted the percutaneous vertebroplasty (PVP) plus interstitial implantation of 125I particles (10 particles) at a local county hospital (Figure 2). Back pain was relieved postoperatively, 3 days after he received PVP combined with interstitial implantation of 125I seeds. However, back pain, bilateral lower extremity weakness, and loss of bladder control reoccurred on day 3 after surgery and got worse. A general physical examination and central nervous system examination upon patient admission revealed abnormal findings. The majority of symptoms encompassed pain and hypoesthesia below the processus xiphoideus. The abdominal reflex, the crissum and cremasteric reflex, and the knee and ankle reflex could not be induced. No pathological reflection of Babinski’s sign was induced. The strengths of the major muscle of both lower limbs were 3 grades and progressively decreased in the postoperative period. The opiate drugs were used to control pain originating from the surgical site. He was admitted to our hospital after 44 postoperative days because of serious back pain. The postoperative transverse computed tomography (CT) revealed bone cements and metallic implants in T4 without any bone cement leakage, but the MRI showed the left intraspinal space-occupying lesion in the T4 vertebral body (Figure 3). And the enhanced CT indicated the possibility of tissue tumor, which was also confirmed by thoracic vertebra magnetic resonance imaging (Figure 3). However, no powerful evidences could be used to confirm that the intraspinal space-occupying lesion was a tissue tumor (Figure 4). In fact, the results of MRI showed the high signal intensity in T2-weighted and fat-suppression images in the T5 body level (Figure 5). Notably, there are several particles located in the vertebral posterior wall without appropriate distribution (Figure 2). The above clinical symptoms may be caused by delayed radiation-induced myelopathy or spinal cord compression. This patient died after 5 months of surgery because of multiple organ failure.

3. Discussion

Spinal metastasis tumor usually causes pathological fracture of the vertebral body leading to the compression of the spinal cord and resulting in severe pain or limb sensory and motor disorders. These can seriously decrease the quality of life of tumor patients even if these populations have short-term life expectancy [6]. The basic therapeutic rationales include relieving pain, rebuilding the stability of the spine, improving the quality of life, and killing the local tumor cell as soon as possible. However, traditional surgical methods and chemotherapy have many defects, such as major trauma, long bedtime rest, long cycles, and significant complication and severe adverse effects [7]. The percutaneous vertebroplasty (PVP) as palliative care can relieve the pain and rebuild the stability for pathological fracture of the vertebral body [8]. Besides, PVP can also kill the tumor cells in virtue of high temperature produced by polymethylmethacrylate (PMMA). However, this method can kill only tumor cells surrounding the PMMA and cannot provide ongoing kill ability [4]. Thus, some researchers combined PVP with the interstitial implantation of 125I seeds in order to acquire ongoing kill ability to tumor cells [4, 5, 911]. For one thing, this novel technique provides stronger anchoring and fixation with the help of PMMA. For another, tumor cells in the diseased vertebral body can be continually killed by gamma rays produced by 125I seeds. The feasibility of this comprehensive method had been proved by a previous physician. But there are limitations of this novel measures because of many potential complications especially delayed radiation-induced myelopathy and intraoperative leakage of bone cement [12, 13].

The relative published literatures indicated that no radioactive myelopathy occurred in the patients who accepted PVP plus interstitial implantation of 125I seeds [5, 6, 911]. We searched PubMed with the following terms: “percutaneous vertebroplasty or PVP” AND “125I seeds” with limitation scope of spinal metastasis tumor and clinical research, and then, we found 5 literatures including 4 clinical studies [5, 6, 10, 11] and 1 case report [9]. The characteristics of the published articles were summarized in Table 1. There are few clinical articles that reported radioactive myelopathy but for bone cement leakage for a patient accepting this novel surgery to therapy spinal metastasis.


Year and authorSize of sampleAge (years)Follow-up time (months)Dosage (seeds per patient)Tools of evaluationComplicationsTherapeutic effects
MaleFemale
Clinical statesRadiological manifestations

2009, Yang et al. [5]2119122.92
5–10
VAS, KPS, RECIST, CT, MRIBone cement leakageAlleviate back pain
Improve quality of life
Acquire spinal stability
Prohibit and kill tumor cells
2011, Zuozhang et al. [9]138362.92VAS, KPS, RECIST, CT, MRINo complications
2012, Yang et al. [10]2030127–20
80–100#
VAS, QLQ-C30, CT, MRILow blood pressure
Low oxygen saturation
High level of thromboses
2014, Li et al. [6]181149.2390–140#VAS, KPS, RECIST, CT, MRIBone cement leakage
2014, Huang et al. [11]10862616-34VAS, KPS, ECT, CTBone cement leakage

cGy/hour/seed; #Gy.

Many factors such as the type of fracture, surgical technique, surgeon’s experiences, suitable implanting location, and proper dose of 125I particles are usually the key to increase the therapeutic efficacy of this combined surgery and reduce risks, especially the suitable implantation location and fitted dose of 125I particles that may bring better therapeutic effectiveness and can avoid radioactive myelopathy, which have been emphasized in previous published literatures [6, 10, 12, 14, 15]. Thus, the surgeon should have skilled technique and rich experience of PVP. Besides, the performer must elaborate the indications of this combined technique and should strictly follow the treatment planning system (TPS). TPS and CT three-dimensional (3D) digital image reconstruction are used to perform evaluation and analysis before this novel surgery. In a previous case report, the surgeon used a TPS software and a 3D digital image to evaluate absorbed dose values based on lesion size and location and analyzed the relationship with surrounding normal tissues [9]. In fact, the dose of 125I particle implantation can be calculated by the surgeon according to 3D icons, isodose curve, absorbed dose value, and relationship with surrounding normal tissues. Our patient accepted the percutaneous vertebroplasty (PVP) plus interstitial implantation of 125I seeds (10 particles) at a local county hospital who has an occurrence of delayed radioactive myelopathy. The postoperative X-ray showed that the location of a part of 125I particles was close to the back wall of the vertebra (Figure 2), which may be the cause of delayed radioactive myelopathy. Thus, the suitable location of implantation with the help of preoperative evaluation and the effective anchoring by means of bone cement are necessary for the surgeon in operative process. Besides, surgeons should strictly follow the indications of this novel surgery. After reviewing five related published clinical studies [6, 10, 12, 14, 15], the following seven main items of indications for PVP plus implantation of 125I particles had been summarized (Figure 6). Firstly, the definite radiographic and physical evidences to confirm spinal metastasis were emphasized in five clinical studies [6, 10, 12, 14, 15]. Secondly, three literatures revealed that back pain with or without neck pain should be considered as the major clinical symptom [10, 14, 15]. Thirdly, other indications are as follows: with more than 3 months of the estimated survival time [6, 10, 12], with normal function of main organs [10, 12], with ability of prone position (more than 2 hours) [10, 12], and without spinal cord or nerve compression [6, 14], which were presented in four published clinical studies. Finally, patients with intelligibility for other surgery and their Frankel degree or KPS scores in preoperative duration were also viewed as indications for this combined surgery [6, 12]. According to the above indications of this novel surgery, the main indications include the definite radiographic and physical evidence, back pain as the major clinical symptoms, and patient with more than three months of the estimated survival time. The second indications consist of normal function of main organs, with ability of prone position (more than 2 hours), and without spinal cord or nerve compression. The patient was suitable for receiving PVP combined with implantation of 125I particles based on the above indications in our report.

Notably, it is difficult to confirm the radiation-induced myelopathy because of unspecific features in clinical and radiological findings [16, 17]. Our report describes a patient with the possibility of postoperative radioactive myelopathy who accepted PVP plus interstitial implantation of 125I seeds as before. The evidences were derived from the bilateral progressiveness of clinical symptoms, negative pathological examination of an intraspinal space-occupying lesion, and the high signal intensity in T2-weighted and fat-suppression images. Actually, the unilateral compression of the spinal cord always leads to the appearance of the Brown-Sequard syndrome rather than bilateral clinical symptoms for both lower extremities. In particular, the improper distribution of 125I particles was found in radiography, which might cause the delayed radioactive myelopathy (Figure 4). In basic researches, actually, the autophagy of neural cells was found in Banna pigs which received 125I seed implantation that was demonstrated by previous researchers [18, 19]. And ultimate apoptosis and necrosis were also observed in the pathological section. In an in vivo study, electron microscopic (EM) observation was performed for subcellular identification. Under EM observation, the obvious impairment was found for most organelles, mitochondria swelled, and apoptosis of neurons was found as well [20]. Based on that, the authors suggested that radiation myelitis due to 125I-based brachytherapy is related to the dose and duration of exposure. Besides, all documents in published articles emphasize the safe distance (greater than 1 cm) ranging from the particles to the spinal cord or vessels [5, 6, 911].

4. Conclusion

The case report describes a 49-year-old man who presented with a possibility of delayed radiation-induced myelopathy after he had accepted PVP combined with local 125I seed implantation. An adverse circumstance occurred which was compared with previous conclusion results from published papers. The complication of radioactive myelopathy or delayed radioactive myelopathy should be paid enough attention by the surgeon. In particular, when the surgeon aims to acquire effective particle distribution, the surgeon should not overlook the safe distance ranging from particles to the spinal cord.

Conflicts of Interest

No potential conflicts of interest relevant to this article exist.

Acknowledgments

This work was supported by the Scientific Program of the Hunan Provincial Health Committee, Hunan Province, China (C2016129 and C20190940), and the Science and Technology Planning Project of Huaihua, Huaihua City, Hunan Province, China (2018N2207).

References

  1. D. R. Fourney, D. F. Schomer, R. Nader et al., “Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients,” Journal of Neurosurgery: Spine, vol. 98, no. 1, pp. 21–30, 2003. View at: Publisher Site | Google Scholar
  2. S. T. E. R. G. I. O. S. Boussios, D. E. I. R. D. R. E. Cooke, C. A. T. H. E. R. I. N. E. Hayward et al., “Metastatic spinal cord compression: unraveling the diagnostic and therapeutic challenges,” Anticancer Research, vol. 38, no. 9, pp. 4987–4997, 2018. View at: Publisher Site | Google Scholar
  3. A. A. Elsamadicy, O. Adogwa, D. T. Lubkin et al., “Thirty-day complication and readmission rates associated with resection of metastatic spinal tumors: a single institutional experience,” Journal of Spine Surgery, vol. 4, no. 2, pp. 304–310, 2018. View at: Publisher Site | Google Scholar
  4. L. Xie, Y. Chen, Y. Zhang et al., “Status and prospects of percutaneous vertebroplasty combined with 125I seed implantation for the treatment of spinal metastases,” World Journal of Surgical Oncology, vol. 13, no. 1, 2015. View at: Publisher Site | Google Scholar
  5. Z. Yang, D. Yang, L. Xie et al., “Treatment of metastatic spinal tumors by percutaneous vertebroplasty versus percutaneous vertebroplasty combined with interstitial implantation of 125I seeds,” Acta Radiologica, vol. 50, no. 10, pp. 1142–1148, 2009. View at: Publisher Site | Google Scholar
  6. T. Li, J. Li, Z. Wang, B. Liu, D. Han, and P. Wang, “Preliminary comparative clinical study of vertebroplasty with multineedle or single-needle interstitial implantation of 125I seeds in the treatment of osteolytic metastatic vertebral tumors,” Journal of Neurosurgery. Spine, vol. 20, no. 4, pp. 430–435, 2014. View at: Publisher Site | Google Scholar
  7. B. A. Georgy, “Vertebroplasty technique in metastatic disease,” Neuroimaging Clinics of North America, vol. 20, no. 2, pp. 169–177, 2010. View at: Publisher Site | Google Scholar
  8. M. E. Jensen, A. J. Evans, J. M. Mathis, D. F. Kallmes, H. J. Cloft, and J. E. Dion, “Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects,” American Journal of Neuroradiology, vol. 18, no. 10, pp. 1897–1904, 1997. View at: Google Scholar
  9. Y. Zuozhang, X. Lin, S. Hongpu et al., “A patient with lung cancer metastatic to the fifth thoracic vertebra and spinal cord compression treated with percutaneous vertebroplasty and I125 seed implantation,” Diagnostic and Interventional Radiology, vol. 17, no. 4, pp. 384–387, 2011. View at: Publisher Site | Google Scholar
  10. Z. Yang, J. Tan, R. Zhao et al., “Clinical investigations on the spinal osteoblastic metastasis treated by combination of percutaneous vertebroplasty and 125I seeds implantation versus radiotherapy,” Cancer Biotherapy and Radiopharmaceuticals, vol. 28, no. 1, pp. 58–64, 2013. View at: Publisher Site | Google Scholar
  11. H. Huang, S. Xu, Z. Du, F. Li, and L. Wang, “Treatment of metastatic thoracolumbar tumors by percutaneous vertebroplasty combined with interstitial implantation of 125I seeds,” Zhonghua Zhong Liu Za Zhi, vol. 36, no. 3, pp. 228–231, 2014. View at: Google Scholar
  12. G. Baroud, M. Crookshank, and M. Bohner, “High-viscosity cement significantly enhances uniformity of cement filling in vertebroplasty: an experimental model and study on cement leakage,” Spine, vol. 31, no. 22, pp. 2562–2568, 2006. View at: Publisher Site | Google Scholar
  13. M. Khan, P. Ambady, D. Kimbrough et al., “Radiation-induced myelitis: initial and follow-up MRI and clinical features in patients at a single tertiary care institution during 20 years,” AJNR. American Journal of Neuroradiology, vol. 39, no. 8, pp. 1576–1581, 2018. View at: Publisher Site | Google Scholar
  14. S. Wang, G. Shi, and X. Meng, “Clinical curative effect of percutaneous vertebroplasty combined with 125I-seed implantation in treating spinal metastatic tumor,” Pakistan Journal of Pharmaceutical Sciences, vol. 28, pp. 1039–1042, 2015. View at: Google Scholar
  15. C.-W. Lu, J. Shao, Y. G. Wu et al., “Which Combination Treatment Is Better for Spinal Metastasis: Percutaneous Vertebroplasty With Radiofrequency Ablation, 125I Seed, Zoledronic Acid, or Radiotherapy?” American Journal of Therapeutics, vol. 26, no. 1, pp. e38–e44, 2019. View at: Publisher Site | Google Scholar
  16. M. Keřkovský, J. Zitterbartová, L. Pour, A. Šprláková-Puková, and M. Mechl, “Diffusion tensor imaging in radiation-induced myelopathy,” Journal of Neuroimaging, vol. 25, no. 5, pp. 836–840, 2015. View at: Publisher Site | Google Scholar
  17. T. Kadir, F. B. Sarica, K. Ozgur, M. Cekinmez, and A. M. Nur, “Delayed radiation myelopathy: differential diagnosis with positron emission tomography/computed tomography examination,” Asian Journal of Neurosurgery, vol. 7, no. 4, pp. 206–209, 2012. View at: Publisher Site | Google Scholar
  18. X. Cao, L. Fang, C. Y. Cui, S. Gao, and T. W. Wang, “DTI and pathological changes in a rabbit model of radiation injury to the spinal cord after 125I radioactive seed implantation,” Neural Regeneration Research, vol. 13, no. 3, pp. 528–535, 2018. View at: Publisher Site | Google Scholar
  19. Z. Yang, Y. Zhang, D. Xu et al., “Percutaneous vertebroplasty combined with interstitial implantation of 125I seeds in banna mini-pigs,” World Journal of Surgical Oncology, vol. 11, no. 1, 2013. View at: Publisher Site | Google Scholar
  20. Z. Yang, Y. Xu, D. Yang et al., “Pathological impairments induced by interstitial implantation of 125I seeds in spinal canal of banna mini-pigs,” World Journal of Surgical Oncology, vol. 10, no. 1, 2012. View at: Publisher Site | Google Scholar

Copyright © 2019 Lunli Xie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views309
Downloads446
Citations

Related articles